Experience with the use of a ketogenic diet with type 1 glucose transporter deficiency (De Vivo disease)
De Vivo disease is characterized by early epileptic encephalopathy, delayed psychomotor development, spasticity, the formation of microcephaly, ataxia, dysarthria, alternating hemiplegia, and a decrease in glucose and lactate levels in the cerebrospinal fluid. Epilepsy is pharmacoresistant and the t...
Saved in:
| Main Author: | N. G. Lyukshina |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2021-11-01
|
| Series: | Русский журнал детской неврологии |
| Subjects: | |
| Online Access: | https://rjdn.abvpress.ru/jour/article/view/377 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Progress of ketogenic diet in the treatment of developmental epileptic encephalopathy
by: Wandong Hu, et al.
Published: (2025-08-01) -
Developmental encephalopathy and epilepsy associated with a heterozygous de novo mutation in the IRF2BPL gene: a case report
by: N. G. Lyukshina, et al.
Published: (2021-07-01) -
Exploring ketogenic diet resistance in glucose transporter type 1 deficiency syndrome: A comprehensive review and critical appraisal
by: Raffaele Falsaperla, et al.
Published: (2025-02-01) -
A novel frameshift variant in the SLC2A1 gene causing a mild phenotype of GLUT1 deficiency syndrome: case report
by: Lívia Maria Ferreira Sobrinho, et al.
Published: (2024-12-01) -
Glucose transporter deficiency syndrome type 1: a case report
by: E. A. Kulish, et al.
Published: (2019-07-01)